CENTOGENE NV (CNTG)
NL0014040206 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 42.23M 9.83% | 47.47M 12.41% | 48.536M 2.25% | 60.69M 25.04% | |
| EBITDA YoY % growth | -33.36M 4.60% | -25.54M 23.44% | -20.416M 20.06% | N/A | |
| EBIT YoY % growth | -54.65M -9.08% | -35.92M 34.27% | -28.026M 21.98% | -40.392M -44.12% | |
| Operating Margin | -129.41% | -75.67% | -57.74% | -66.55% | |
| EPS YoY % growth | -2.06 -98.08% | -1.42 31.07% | N/A -14.93% | -0.99 39.38% |
All data in EUR
| Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.28 28.95% | -0.28 27.03% | -0.24 45.45% | -0.21 38.24% |
| Revenue Q2Q % growth | 14.28M 9.80% | 14.79M -39.88% | 15.3M 30.43% | 16.32M -66.38% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.302M -11.32% | -10.2M 49.66% | -10.098M 8.33% | -9.792M 65.52% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -285.33% | -0.35 | % | |
| Q3 2023 Q2Q % growth | 4.51% | -0.45 | % | |
| Q2 2023 Q2Q % growth | 0.68% | -0.38 | % | |
| Q1 2023 Q2Q % growth | 19.25% | -0.39 | % | |
| Q4 2022 Q2Q % growth | -0.09 82.35% | -0.38 | 0.29 | 76.15% |
| Q3 2022 Q2Q % growth | -0.47 51.04% | -0.41 | -0.06 | -15.20% |
| Q2 2022 Q2Q % growth | -0.38 -2.70% | -0.40 | 0.02 | 4.47% |
| Q1 2022 Q2Q % growth | -0.48 -118.18% | -0.51 | 0.03 | 5.88% |
| Q4 2021 Q2Q % growth | -0.51 -383.33% | -0.64 | 0.13 | 20.63% |
| Q3 2021 Q2Q % growth | -0.96 -255.56% | -0.50 | -0.46 | -92.08% |
| Q2 2021 Q2Q % growth | -0.37 28.85% | -0.24 | -0.13 | -54.69% |
| Q1 2021 Q2Q % growth | -0.22 48.84% | 0.04 | -0.26 | -626.06% |
| Q4 2020 Q2Q % growth | 0.18 171.15% | -0.08 | 0.26 | 320.59% |
| Q3 2020 Q2Q % growth | -0.27 | -0.24 | -0.03 | -14.22% |
| Q2 2020 Q2Q % growth | -0.52 | -0.37 | -0.15 | -41.61% |
| Q1 2020 Q2Q % growth | -0.43 | -0.33 | -0.10 | -29.05% |
| Q4 2019 Q2Q % growth | -0.25 | -0.17 | -0.09 | -51.86% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 48.536M 254.74% | 12.75M | 35.786M | 280.67% |
| Q3 2023 Q2Q % growth | -5.43% | 11.73M | % | |
| Q2 2023 Q2Q % growth | 24.6M 119.64% | 13.515M | 11.085M | 82.02% |
| Q1 2023 Q2Q % growth | 27.63% | 13.005M | % | |
| Q4 2022 Q2Q % growth | 13.682M 296.58% | 13.77M | -88K | -0.64% |
| Q3 2022 Q2Q % growth | 12.403M -58.93% | 12.75M | -347K | -2.72% |
| Q2 2022 Q2Q % growth | 11.2M 21.61% | 11.788M | -588K | -4.99% |
| Q1 2022 Q2Q % growth | 10.19M 4.09% | 29.53M | -19.34M | -65.49% |
| Q4 2021 Q2Q % growth | -6.96M 64.63% | 33.659M | -40.619M | -120.68% |
| Q3 2021 Q2Q % growth | 30.2M -16.83% | 28.723M | 1.477M | 5.14% |
| Q2 2021 Q2Q % growth | 9.21M -5.25% | 42.191M | -32.981M | -78.17% |
| Q1 2021 Q2Q % growth | 9.79M -19.16% | 60.314M | -50.524M | -83.77% |
| Q4 2020 Q2Q % growth | -19.68M -229.30% | 43.343M | -63.023M | -145.41% |
| Q3 2020 Q2Q % growth | 36.31M 211.94% | 23.802M | 12.508M | 52.55% |
| Q2 2020 Q2Q % growth | 9.72M -13.29% | 11.578M | -1.858M | -16.05% |
| Q1 2020 Q2Q % growth | 12.11M 12.97% | 13.305M | -1.195M | -8.98% |
| Q4 2019 Q2Q % growth | 15.22M | 15.352M | -132K | -0.86% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |